Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation

Annals of Thoracic Surgery

Volumn 69, Issue 3, 2000, Pages 750-754

  Johnsson, Per ^a   Blomquist, Sten ^b   Lührs, Carsten ^a   Malmkvist, Gunnar ^a   Alling, Christer ^a   Solem, Jan Otto ^a   Ståhl, Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; HEMOGLOBIN; NEURON SPECIFIC ENOLASE;

ADULT; AGED; ARTICLE; BRAIN INJURY; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; ELECTIVE SURGERY; ENZYME BLOOD LEVEL; ENZYME METABOLISM; ENZYME RELEASE; ERYTHROCYTE; EXTRACORPOREAL CIRCULATION; FEMALE; HALF LIFE TIME; HEART PERFUSION; HEART SURGERY; HEMOLYSIS; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; EXTRACORPOREAL CIRCULATION; FEMALE; HEMOGLOBINS; HEMOLYSIS; HUMANS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; TIME FACTORS;

EID: 0034126014     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01393-4     Document Type: Article

References (19)

1. Shaw P.J., Bates D., Cartlidge N.E.F., et al. Early intellectual dysfunction following coronary bypass surgery. Q J Med. 58:1986;59-68.
2. Smith P.L., Treasure T., Newman S.P., et al. Cerebral consequences of cardiopulmonary bypass. Lancet. 1:1986;823-825.
3. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology. 72:1990;153-184.
4. Croughwell N.D., Newman M.F., Blumenthal J.A., et al. Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. Ann Thorac Surg. 58:1994;1702-1708.
5. Schmechel D., Marangos P.J., Brightman M. Neuron-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature. 276:1978;834-836.
6. Påhlman S., Esscher T., Bergvall P., Odelstad L. Purification and characterization of human neuron-specific enolase radioimmunoassay method . Tumor Biol. 5:1984;127-139.
7. Notomi T., Morikawa J., Kato K., Tsuchida Y., Ohsawa R. Radioimmunoassay development for human neuron-specific enolase with some results in lung cancer and neuroblastoma . Tumor Biol. 6:1985;57-66.
8. Hans P., Bonhomme V., Colette J., Moonen G. Neuron-specific enolase as a marker of in vitro neuronal damage. Part I: Assessment of neuron-specific enolase as a quantitative and specific marker of neuronal damage . J Neurosurg Anesthesiol. 5:1993;111-116.
9. Hårdemark H.-G., Ericsson N., Kotwica Z., et al. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg. 71:1989;727-731.
10. 0α, 28-kDa calbindin-D, S-100b and CK-BB) in serum and cerebrospinal fluid after cardiac arrest. J Neurol Sci. 123:1994;134-139.
11. Persson L., Hårdemark H.-G., Gustafsson J., et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum markers of cell damage in human central nervous system . Stroke. 18:1987;911-918.
12. Dauberschmidt R., Zinsmeyer J., Mrochen H., Meyer M. Changes of neuron-specific enolase in plasma after cardiac arrest and resuscitation. Mol Chem Neuropathol. 14:1991;237-245.
13. Kärkelä J., Bock E., Kaukinen S. CSF and serum brain-specific creatinine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci. 116:1993;100-109.
14. Schaarschmidt H., Prange H., Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 25:1994;558-565.
15. Parnetti L., Palumbo B., Cardinali L., et al. Cerebrospinal fluid neuron-specific enolas in Alzheimer's disease and vascular dementia. Neurosci Lett. 183:1995;43-45.
16. De Giorgio C., Correale J., Gott P., et al. Serum neuron-specific enolase in human status epilepticus. Neurology. 45:1995;1134-1137.
17. Lamers K., van Ewngelen B., Gabreels F., et al. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol Scand. 92:1995;247-251.
18. Johnsson P., Lundqvist C., Lindgren A., Ferencz I., Alling C., Ståhl E. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. J Cardiothorac Vasc Anesth. 9:1995;694-699.
19. Gao F., Harris D.N.F., Sapsed-Byrne S., Sharp S. Neuron-specific enolase and Sangtec-100 assays during cardiac surgery. Part III: does haemolysis affect their accuracy? Perfusion. 12:1997;171-177.